氟替卡松雾化吸入在治疗支气管哮喘中的效果研究

Experience of Fluticasone Aerosol Inhalation in the Treatment of Bronchial Asthma

目的:探讨分析氟替卡松雾化吸入在支气管哮喘中的治疗效果。方法:选取2016年10月-2018年10月在笔者所在医院呼吸内科就诊的80例支气管哮喘患者作为本次的研究对象,随机分为研究组和对照组,各40例。对照组采用常规疗法进行治疗,研究组采用氟替卡松进行治疗,统计分析两组的临床疗效情况、肺功能改善情况。结果:研究组临床治疗总有效率为97.50%,对照组为77.50%,差异有统计学意义(P<0.05);研究组肺功能改善情况显著优于对照组(P<0.05)。结论:在支气管哮喘的临床治疗中应用氟替卡松价值极高,对患者的临床疗效更好,患者的肺功能改善情况更好。

Objective:To explore the therapeutic effect of Fluticasone aerosol inhalation in bronchial asthma.Method:80 patients with bronchial asthma who were treated in Respiratory Medicine Department of our hospital from October 2016 to October 2018 were selected as the subjects of this study.The subjects were randomly divided into the study group and the control group,40 cases each.The control group was treated with conventional therapy,while the study group was treated with Fluticasone.The clinical efficacy and pulmonary function of the two groups were analyzed.Result:The total effective rate was 97.50% in the study group and 77.50% in the control group,there was significant difference(P<0.05),the improvement of lung function in the study group was significantly better than that in the control group(P<0.05).Conclusion:Fluticasone is of great value in the clinical treatment of bronchial asthma.It has better clinical effect and better improvement of pulmonary function in patients with bronchial asthma.